Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03685357
Other study ID # AinShamsUni Afnan
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date July 1, 2018
Est. completion date January 2020

Study information

Verified date September 2018
Source Ain Shams University
Contact Afnan Elgnainy
Phone 01061840761
Email Afnan.elgnainy@pharma.asu.edu.eg
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Correlation between Idiopathic Parkinson's disease and diabetes mellitus in Egyptian Elderly Patients


Description:

1. Record RBDSQ ("Rapid eye movement Sleep" Behavior Disorder Screening Questionnaire) total score difference between Group 1 and Group 2 .

2. Oral glucose tolerance test will be performed and compared between Group 3 and Group 4.

3. Association between glucose level and motor complication of L-dopa among Idiopathic Parkinson's patients using Unified Parkinson's Disease Rating Scale (UDPRS).


Recruitment information / eligibility

Status Recruiting
Enrollment 120
Est. completion date January 2020
Est. primary completion date June 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

1. Diabetic Patients

2. Idiopathic Parkinsonism

Exclusion Criteria:

1. Secondary Parkinsonism due to stroke, trauma and encephalitis.

2. Drug induced Parkinsonism.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Egypt AinShams University Cairo

Sponsors (2)

Lead Sponsor Collaborator
Ain Shams University Al-Azhar University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary UPDRS (Unified Parkinson's Disease Rating) Scale) Association between glucose level and motor complication of L-dopa among Idiopathic , , Parkinson's patients using Unified Parkinson's Disease Rating Scale (UDPRS)., high scores mean worsen condition Baseline
Primary Oral Glucose Tolerance Test Between Idiopathic Parkinson's patients and the Control group 0, 0.5 hour , 1 hour, 1.5 hour , 2 hour
Primary RBDSQ ("Rapid eye movement Sleep" Behavior Disorder Screening Questionnaire) among Diabetic Patients, total score 13 , high scores mean worsen condition Baseline
See also
  Status Clinical Trial Phase
Completed NCT03051815 - Influence of Craniofacial Restriction on Rebound of Obstructive Sleep Apnea Following Weight Gain
Completed NCT02838641 - Application of GeneXpert on Bronchoscopic Samples for Patients Suspicious of TB
Not yet recruiting NCT03691389 - Investigating the Relationship Between Parents and Their Children With ADHD and Conduct Disorder